NYSE · REAL ESTATE INVESTMENT TRUSTS · LARGE CAP
National Health Investors Inc. NHI
18 fiscal years on record · USD · FY2025 reported · SEC filings only
In brief
What this company does
Written from the business description in National Health Investors, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 26 February 2026. Every sentence was checked against that document before publication.
Growth
USD 80.1M
Revenue, FY2025 · full 18-year series below
Revenue $M
Net income $M
FY2025 · Revenue 80.1 · Net income 142.2
Compound annual growth
+30.8%
−10.0%
−0.2%
+28.9%
−5.1%
−0.5%
+4.9%
+26.8%
−6.1%
−2.6%
+1.3%
+0.4%
−3.8%
+0.7%
+2.9%
−18.5%
−2.7%
+3.1%
+6.4%
3 yrs
5 yrs
10 yrs
15 yrs
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
176 cents
of every revenue dollar became profit
Operating margin
Net margin
FY2025 · Operating — · Net 175.8%
ROE
FY2025 · ROE 9.8%
Each USD of equity produced 10 cents of profit this year.
The 18-year record
18 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue $B | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Operating income $B | · | · | · | · | · | · | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 |
| EBITDA $B | · | · | · | · | · | · | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | · | · | · | · | · | · |
| Income tax $B | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | −0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | · |
| Net income $B | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Free cash flow $B | −0.1 | 0.0 | 0.1 | 0.2 | 0.2 | 0.1 | 0.0 | 0.1 | 0.0 | −0.2 | 0.0 | −0.4 | −0.6 | −0.0 | 0.0 | −0.0 | −0.0 | 0.1 |
| EPS, diluted $ | 3.02 | 3.13 | 3.13 | 1.48 | 2.44 | 4.14 | 3.67 | 3.67 | 3.87 | 3.87 | 3.95 | 3.04 | 3.74 | 3.26 | 2.92 | 2.50 | 2.32 | 2.07 |
| Dividend / sh $ | 3.64 | 3.60 | 3.60 | 3.60 | 3.80 | 4.41 | 4.20 | 4.00 | 3.80 | 3.60 | 3.40 | 3.08 | 2.90 | 2.86 | 2.71 | 2.36 | 2.30 | 2.42 |
| Payout % | 119 | 113 | 115 | 244 | 164 | 105 | 112 | 107 | 96 | 91 | 84 | 99 | 80 | 87 | 84 | 96 | 100 | 149 |
| ROE % | 9.8 | 10.5 | 10.7 | 4.8 | 7.4 | 12.3 | 11.1 | 11.1 | 13.2 | 12.9 | 13.7 | 11.2 | 17.4 | 20.1 | 18.3 | · | · | · |
| Shares out B | 0.05 | 0.05 | 0.04 | 0.04 | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | 0.00 | 0.00 |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Provenance
Company facts, as filed
How we verify · 0 failures in 53 reconciliationsAUDITED
Reconciled in 18 of 19 fiscal years. 7 checks could not be computed.
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityReal Estate Investment Trusts
Listed onNYSE
Incorporated inMaryland
Fiscal year endsDecember 31
Data on record since2008